Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
17.40B | 17.22B | 25.27B | 44.70B | 64.45B | 60.60B | Gross Profit |
18.21B | 17.22B | 25.27B | 44.70B | 64.45B | 60.60B | EBIT |
9.47B | -2.07B | 16.00M | 3.97B | 3.57B | 2.99B | EBITDA |
5.47B | 5.93B | 4.00B | 3.72B | 4.74B | 3.82B | Net Income Common Stockholders |
3.97B | 4.07B | 2.87B | 3.73B | 3.26B | 3.08B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
25.99B | 24.71B | 19.38B | 18.84B | 17.23B | 7.95B | Total Assets |
804.14B | 802.16B | 713.23B | 701.46B | 630.49B | 600.49B | Total Debt |
9.54B | 10.23B | 9.65B | 11.29B | 9.73B | 10.71B | Net Debt |
-403.00M | 664.00M | 2.60B | 4.88B | 4.96B | 2.76B | Total Liabilities |
771.05B | 771.01B | 683.38B | 669.14B | 600.00B | 573.48B | Stockholders Equity |
29.91B | 29.54B | 26.84B | 29.01B | 27.22B | 24.03B |
Cash Flow | Free Cash Flow | ||||
4.33B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B | Operating Cash Flow |
4.33B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B | Investing Cash Flow |
-196.00M | -408.00M | -786.00M | -5.49B | -11.21B | -8.20B | Financing Cash Flow |
-2.44B | -2.29B | -3.55B | -620.00M | -992.00M | 2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | C$47.63B | 12.36 | 14.65% | 4.43% | 17.48% | 25.54% | |
64 Neutral | $12.77B | 9.77 | 7.59% | 16985.66% | 12.31% | -7.69% | |
$54.81B | 16.66 | 10.17% | 3.75% | ― | ― | ||
$36.69B | 16.52 | 13.18% | 3.71% | ― | ― | ||
$40.78B | 9.11 | 17.21% | 0.92% | ― | ― | ||
77 Outperform | C$13.05B | 14.79 | 12.54% | 2.52% | -7.31% | 28.65% | |
72 Outperform | C$33.38B | 12.27 | 11.92% | 4.41% | 7.63% | 8.84% |
Great-West Lifeco has appointed Lindsey Rix-Broom as CEO of its European operations, effective July 1, 2025. Rix-Broom, who currently leads Canada Life U.K., is recognized for her leadership and strategic focus, having driven significant growth and modernization in the U.K. market. Her appointment is part of a broader leadership transition, with David Harney taking over as President & CEO of Great-West Lifeco and Canada Life. This strategic move aims to strengthen Lifeco’s presence in Europe, particularly in the U.K., Ireland, and Germany, as the company continues to focus on delivering sustainable growth and value.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco announced the election of all 19 director nominees during its Annual and Special Meeting of Shareholders. The election results showed strong support for the nominees, indicating stability and continuity in the company’s governance. This decision is expected to reinforce Great-West Lifeco’s strategic direction and maintain its robust position in the financial services industry, benefiting stakeholders by ensuring consistent leadership.
Great-West Lifeco reported strong first quarter 2025 results, with base earnings of $1.0 billion, marking a 5% increase from the previous year, driven by growth in its Retirement and Wealth businesses. Despite a 17% decline in net earnings from continuing operations due to unfavorable market conditions, the company maintained a robust capital position with a LICAT ratio of 130% and continued its strategic focus on capital-efficient growth, particularly in the U.S. segment, which contributed significantly to its performance.
Great-West Lifeco announced the retirement of Paul Mahon as President and CEO, effective July 1, 2025, with David Harney set to succeed him. Mahon, who has been instrumental in repositioning the company and leading it through significant transformations, will remain as a Senior Advisor until early 2026 to ensure a smooth transition. Harney, with over 35 years at the company and a proven track record in leadership roles, is expected to continue driving Lifeco’s growth strategy and strengthening its market presence.
Great-West Lifeco announced it will release its first quarter 2025 financial results on May 7, with a subsequent earnings conference call and webcast scheduled for May 8. The company will also hold its Annual and Special Meetings on May 8, allowing registered shareholders and policyholders to participate in person or virtually. These events are significant as they provide stakeholders with insights into the company’s financial performance and strategic direction.
Great-West Lifeco Inc. hosted its 2025 Investor Day in Toronto, focusing on the theme ‘Driving Growth, Delivering Lasting Value.’ The company updated its medium-term financial objectives, including an increase in its Base Return on Equity objective to 19% or more, up from 16-17%. Additionally, it introduced a new objective for Base Capital Generation of 80% or more and reaffirmed its confidence in achieving Base EPS growth of 8-10% and a Base Dividend Payout Ratio of 45-55%. These updates reflect the company’s strategic focus on building market-leading franchises and delivering value for shareholders through strong cash and capital generation.
Great-West Lifeco has updated its Supplemental Information Package for 2025, offering more detailed segment reporting and enhanced disclosure of assets under management and advisement. These changes aim to provide greater clarity and transparency for analysts and investors, particularly in the Retirement and Wealth lines of business. The update also includes a new efficiency ratio metric and reclassification of certain expenses to improve understanding of expense management and capital allocation.